company background image
SLV

Selvita WSE:SLV Stock Report

Last Price

zł86.00

Market Cap

zł1.6b

7D

2.4%

1Y

20.1%

Updated

03 Oct, 2022

Data

Company Financials +
SLV fundamental analysis
Snowflake Score
Valuation0/6
Future Growth5/6
Past Performance2/6
Financial Health5/6
Dividends0/6

SLV Stock Overview

Selvita S.A. operates as a contract research organization in Poland, rest of Europe, the United States, and internationally.

Selvita S.A. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Selvita
Historical stock prices
Current Share Pricezł86.00
52 Week Highzł89.90
52 Week Lowzł54.60
Beta0.27
1 Month Change15.59%
3 Month Change24.64%
1 Year Change20.11%
3 Year Changen/a
5 Year Changen/a
Change since IPO309.52%

Recent News & Updates

Jun 09
Selvita (WSE:SLV) Seems To Use Debt Quite Sensibly

Selvita (WSE:SLV) Seems To Use Debt Quite Sensibly

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Shareholder Returns

SLVPL Life SciencesPL Market
7D2.4%6.0%-2.2%
1Y20.1%-34.3%-36.0%

Return vs Industry: SLV exceeded the Polish Life Sciences industry which returned -36.8% over the past year.

Return vs Market: SLV exceeded the Polish Market which returned -36% over the past year.

Price Volatility

Is SLV's price volatile compared to industry and market?
SLV volatility
SLV Average Weekly Movement4.7%
Life Sciences Industry Average Movement7.1%
Market Average Movement6.1%
10% most volatile stocks in PL Market11.6%
10% least volatile stocks in PL Market3.9%

Stable Share Price: SLV is less volatile than 75% of Polish stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: SLV's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2007856Boguslaw Sieczkowskihttps://selvita.com

Selvita S.A. operates as a contract research organization in Poland, rest of Europe, the United States, and internationally. It operates in two segments, Contract Research Organization (CRO) services, and Bioinformatics. The company offers drug discovery services in the areas of assay development and screening, medicinal and synthetic chemistry, computer-aided drug design/ artificial intelligence, structural biology, in vitro/ In Vivo pharmacology, ADME/DMPK and analytical testing.

Selvita S.A. Fundamentals Summary

How do Selvita's earnings and revenue compare to its market cap?
SLV fundamental statistics
Market Capzł1.58b
Earnings (TTM)zł14.44m
Revenue (TTM)zł373.02m

109.3x

P/E Ratio

4.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
SLV income statement (TTM)
Revenuezł373.02m
Cost of Revenuezł67.35m
Gross Profitzł305.67m
Other Expenseszł291.23m
Earningszł14.44m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

Nov 09, 2022

Earnings per share (EPS)0.79
Gross Margin81.95%
Net Profit Margin3.87%
Debt/Equity Ratio36.5%

How did SLV perform over the long term?

See historical performance and comparison